P040013S007

None

FDA Premarket Approval P040013 S007

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP040013S007
Classification NameNone
Applicant
PMAP040013
SupplementS007

Supplemental Filings

Supplement NumberDateSupplement Type
P040013Original Filing
S025 2020-11-27 Real-time Process
S024 2020-04-17 Normal 180 Day Track No User Fee
S023 2020-03-24 Normal 180 Day Track No User Fee
S022 2019-03-21 Normal 180 Day Track No User Fee
S021 2015-06-22 Normal 180 Day Track No User Fee
S020 2015-01-21 Special (immediate Track)
S019 2014-05-05 135 Review Track For 30-day Notice
S018 2012-02-29 Special (immediate Track)
S017 2011-06-24 Normal 180 Day Track No User Fee
S016 2010-12-11 Normal 180 Day Track
S015 2009-08-14 Normal 180 Day Track No User Fee
S014 2009-07-06 Normal 180 Day Track No User Fee
S013 2008-03-26 Normal 180 Day Track
S012 2007-11-23 Normal 180 Day Track No User Fee
S011 2007-05-22 135 Review Track For 30-day Notice
S010
S009 2006-12-22 Special (immediate Track)
S008 2006-10-20 30-day Notice
S007
S006 2006-08-09 30-day Notice
S005 2006-07-31 Real-time Process
S004 2006-05-31 Normal 180 Day Track No User Fee
S003 2006-04-06 Normal 180 Day Track No User Fee
S002 2006-02-27 Real-time Process
S001

NIH GUDID Devices

Device IDPMASupp
00850001118002 P040013 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.